Literature DB >> 28496611

Atrial Fibrillation Progression: New Insight in TheNatural History of This Arrhythmia.

Sanjay Dixit1.   

Abstract

Entities:  

Year:  2009        PMID： 28496611      PMCID： PMC5395037          DOI： 10.4022/jafib.156

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


× No keyword cloud information.
  12 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

Review 2.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

3.  Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Douglas Packer; Allan Skanes
Journal:  Circulation       Date:  2005-02-21       Impact factor: 29.690

4.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

Authors:  Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

5.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-08-15       Impact factor: 24.094

6.  A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.

Authors:  Carlo Pappone; Giuseppe Augello; Simone Sala; Filippo Gugliotta; Gabriele Vicedomini; Simone Gulletta; Gabriele Paglino; Patrizio Mazzone; Nicoleta Sora; Isabelle Greiss; Andreina Santagostino; Laura LiVolsi; Nicola Pappone; Andrea Radinovic; Francesco Manguso; Vincenzo Santinelli
Journal:  J Am Coll Cardiol       Date:  2006-10-16       Impact factor: 24.094

7.  Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.

Authors:  H J Crijns; I C Van Gelder; W H Van Gilst; H Hillege; A M Gosselink; K I Lie
Journal:  Am J Cardiol       Date:  1991-08-01       Impact factor: 2.778

8.  Atrial fibrillation progression and management: a 5-year prospective follow-up study.

Authors:  Carlo Pappone; Andrea Radinovic; Francesco Manguso; Gabriele Vicedomini; Giuseppe Ciconte; Stefania Sacchi; Patrizio Mazzone; Gabriele Paglino; Simone Gulletta; Simone Sala; Vincenzo Santinelli
Journal:  Heart Rhythm       Date:  2008-08-17       Impact factor: 6.343

9.  Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care.

Authors:  Carsten W Israel; Gerian Grönefeld; Joachim R Ehrlich; Yi-Gang Li; Stefan H Hohnloser
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

10.  Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study.

Authors:  Pierre Jaïs; Bruno Cauchemez; Laurent Macle; Emile Daoud; Paul Khairy; Rajesh Subbiah; Mélèze Hocini; Fabrice Extramiana; Fréderic Sacher; Pierre Bordachar; George Klein; Rukshen Weerasooriya; Jacques Clémenty; Michel Haïssaguerre
Journal:  Circulation       Date:  2008-11-24       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.